CytoTools AG announced that it has issued 1,109,498 common shares at an issue price of 3.95 per share for gross proceeds of 4,382,517.1 on May 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.488 EUR | +4.27% | +3.83% | +9.42% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 2.68M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- T5O Stock
- News bioXXmed AG
- CytoTools AG announced that it has received €4.382517 million in funding